Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034708759> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2034708759 endingPage "253" @default.
- W2034708759 startingPage "253" @default.
- W2034708759 abstract "Experimental studies have found several calcium channel blockers with anticonvulsant property. Flunarizine is one of the most potent calcium channel blockers, which has shown anticonvulsant effect against pentylenetetrazole (PTZ) and maximal electroshock (MES)-induced seizures. However, further experimental and clinical trials have shown varied results. We conducted a PTZ model experimental study to re-evaluate the potential of flunarizine for add-on therapy in the management of refractory epilepsy.Experiments were conducted in PTZ model involving Swiss strain mice. Doses producing seizures in 50% and 99% mice, i.e. CD(50) and CD(99) values of PTZ were obtained from the dose-response study. Animals received graded, single dose of sodium valproate (100-300 mg/kg), lamotrigine (3-12 mg/kg) and flunarizine (5-20 mg/kg), and then each group of mice was injected with CD(99) dose of PTZ (65mg/kg i.p.). Another group of mice received single ED(50) dose (dose producing seizure protection in 50% mice) of sodium valproate and flunarizine separately in left and right side of abdomen. Results were analysed by Kruskal-Wallis ANOVA on Ranks test.As compared to control, sodium valproate at 250 mg/kg and 300 mg/kg produced statistical significant seizure protection. At none of the pre-treatment dose levels of lamotrigine, the seizure score with PTZ differed significantly from that observed in the vehicle-treated group. Pre-treatment with flunarizine demonstrated dose-dependent decrease in the seizure score to PTZ administration. As compared to control group, flunarizine at 20 mg/kg produced statistical significant seizure protection.As combined use of sodium valproate and flunarizine has shown significant seizure protection in PTZ model, flunarizine has a potential for add-on therapy in refractory cases of partial seizures. It is therefore, we conclude that further experimental studies and multicenter clinical trials involving large sample size are needed to establish flunarizine as add-on therapy in refractory epilepsy." @default.
- W2034708759 created "2016-06-24" @default.
- W2034708759 creator A5044389615 @default.
- W2034708759 creator A5066800693 @default.
- W2034708759 creator A5087900012 @default.
- W2034708759 date "2011-01-01" @default.
- W2034708759 modified "2023-09-23" @default.
- W2034708759 title "Experimental re-evaluation of flunarizine as add-on antiepileptic therapy" @default.
- W2034708759 doi "https://doi.org/10.4103/0975-7406.80782" @default.
- W2034708759 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3103921" @default.
- W2034708759 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21687355" @default.
- W2034708759 hasPublicationYear "2011" @default.
- W2034708759 type Work @default.
- W2034708759 sameAs 2034708759 @default.
- W2034708759 citedByCount "4" @default.
- W2034708759 countsByYear W20347087592015 @default.
- W2034708759 countsByYear W20347087592016 @default.
- W2034708759 countsByYear W20347087592019 @default.
- W2034708759 crossrefType "journal-article" @default.
- W2034708759 hasAuthorship W2034708759A5044389615 @default.
- W2034708759 hasAuthorship W2034708759A5066800693 @default.
- W2034708759 hasAuthorship W2034708759A5087900012 @default.
- W2034708759 hasBestOaLocation W20347087591 @default.
- W2034708759 hasConcept C118552586 @default.
- W2034708759 hasConcept C126322002 @default.
- W2034708759 hasConcept C178790620 @default.
- W2034708759 hasConcept C185592680 @default.
- W2034708759 hasConcept C2775858608 @default.
- W2034708759 hasConcept C2776414672 @default.
- W2034708759 hasConcept C2777172819 @default.
- W2034708759 hasConcept C2777286116 @default.
- W2034708759 hasConcept C2778186239 @default.
- W2034708759 hasConcept C2778802184 @default.
- W2034708759 hasConcept C2779253243 @default.
- W2034708759 hasConcept C42219234 @default.
- W2034708759 hasConcept C50952357 @default.
- W2034708759 hasConcept C519063684 @default.
- W2034708759 hasConcept C537181965 @default.
- W2034708759 hasConcept C71924100 @default.
- W2034708759 hasConcept C85520022 @default.
- W2034708759 hasConcept C98274493 @default.
- W2034708759 hasConceptScore W2034708759C118552586 @default.
- W2034708759 hasConceptScore W2034708759C126322002 @default.
- W2034708759 hasConceptScore W2034708759C178790620 @default.
- W2034708759 hasConceptScore W2034708759C185592680 @default.
- W2034708759 hasConceptScore W2034708759C2775858608 @default.
- W2034708759 hasConceptScore W2034708759C2776414672 @default.
- W2034708759 hasConceptScore W2034708759C2777172819 @default.
- W2034708759 hasConceptScore W2034708759C2777286116 @default.
- W2034708759 hasConceptScore W2034708759C2778186239 @default.
- W2034708759 hasConceptScore W2034708759C2778802184 @default.
- W2034708759 hasConceptScore W2034708759C2779253243 @default.
- W2034708759 hasConceptScore W2034708759C42219234 @default.
- W2034708759 hasConceptScore W2034708759C50952357 @default.
- W2034708759 hasConceptScore W2034708759C519063684 @default.
- W2034708759 hasConceptScore W2034708759C537181965 @default.
- W2034708759 hasConceptScore W2034708759C71924100 @default.
- W2034708759 hasConceptScore W2034708759C85520022 @default.
- W2034708759 hasConceptScore W2034708759C98274493 @default.
- W2034708759 hasIssue "2" @default.
- W2034708759 hasLocation W20347087591 @default.
- W2034708759 hasLocation W20347087592 @default.
- W2034708759 hasLocation W20347087593 @default.
- W2034708759 hasLocation W20347087594 @default.
- W2034708759 hasOpenAccess W2034708759 @default.
- W2034708759 hasPrimaryLocation W20347087591 @default.
- W2034708759 hasRelatedWork W1954411904 @default.
- W2034708759 hasRelatedWork W2029960324 @default.
- W2034708759 hasRelatedWork W2034708759 @default.
- W2034708759 hasRelatedWork W2103165628 @default.
- W2034708759 hasRelatedWork W2120756984 @default.
- W2034708759 hasRelatedWork W2121312088 @default.
- W2034708759 hasRelatedWork W2411618962 @default.
- W2034708759 hasRelatedWork W3163009628 @default.
- W2034708759 hasRelatedWork W4280582172 @default.
- W2034708759 hasRelatedWork W948604820 @default.
- W2034708759 hasVolume "3" @default.
- W2034708759 isParatext "false" @default.
- W2034708759 isRetracted "false" @default.
- W2034708759 magId "2034708759" @default.
- W2034708759 workType "article" @default.